Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 96Rectal Neoplasms 42Colonic Neoplasms 38Stomach Neoplasms 31Pancreatic Neoplasms 31Neoplasm Metastasis 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Neoplasms 21Esophageal Neoplasms 19Burkitt Lymphoma 15Adenocarcinoma Of Esophagus 14Lymphoma 13Leukemia 8Adenocarcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Osteosarcoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Leukemia, Biphenotypic, Acute 4Gastrointestinal Neoplasms 4Gallbladder Neoplasms 4Carcinoma, Hepatocellular 4Liver Neoplasms 3Intestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Bile Duct Neoplasms 3Somatostatinoma 2

Interventions

Gemcitabine 4pembrolizumab 2Leucovorin 2Irinotecan 2Fluorouracil 2Albumin-Bound Paclitaxel 24-fluorobenzoyl-TN-14003 2regorafenib 1olaparib 1irinotecan sucrosofate 1ibrutinib 1adavosertib 1Paclitaxel 1PEGPH20 1Oxaliplatin 1Drug Therapy 1Docetaxel 1Cisplatin 1Capecitabine 1BKT140 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Metastatic Pancreatic Adenocarcinoma × Leucovorin × Clear all
NCT02826486 2024-08-28

COMBAT

BioLineRx, Ltd.

Phase 2 Completed
80 enrolled 13 charts
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT01959139 2024-02-09

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

SWOG Cancer Research Network

Phase 1/2 Completed
126 enrolled 19 charts
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡